Tenax Therapeutics Files Prospectus For Offering $300M Securities

Benzinga Newsdesk www.benzinga.com Neutral 93.7%

Neg 0% Neu 93.7% Pos 0%

https://www.sec.gov/Archives/edgar/data/34956/000165495426002661/tennx_s3.htm

Comments

No comments yet. Be the first!